THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
MARKET MOVERS

Quest Diagnostics Inc.

July 21, 2011

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

The biggest US operator of medical laboratories fell the most in six months after sluggish demand for its products caused the company to cut its annual forecast. Quest narrowed its 2011 earnings outlook to $4.25 a share to $4.35 a share and cut its sales-growth forecast to 1.5 percent.